Skip to main navigation
Skip to search
Skip to main content
Universidad de los Andes Home
English
Español
!!Search content at Universidad de los Andes
Home
Profiles
Research units
Research output
Projects
Press/Media
Activities
Equipment
Student theses
Prizes
Courses
Impacts
Innate immunity modulation by the IL-33/ST2 system in intestinal mucosa
Marina García-Miguel
, M. Julieta González
,
Rodrigo Quera
, Marcela A. Hermoso
*
*
Corresponding author for this work
Clínica Universidad de los Andes
Research output
:
Contribution to journal
›
Review article
›
peer-review
12
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Innate immunity modulation by the IL-33/ST2 system in intestinal mucosa'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Inflammatory Bowel Disease
100%
Interleukin-33 (IL-33)
100%
Immunomodulation
100%
Innate Immunity
100%
Intestinal mucosa
100%
Ulcerative Colitis
66%
Innate Immune Response
33%
Unknown Etiology
33%
Immune System
33%
Intolerance
33%
Chronic Disease
33%
Intestine
33%
Gastrointestinal Tract
33%
System Damage
33%
Ulcerative Colitis Patient
33%
Contact Surface Area
33%
Intestinal Inflammation
33%
Food Digestion
33%
Global Prevalence
33%
Food Play
33%
Outside Environment
33%
Commensal Bacteria
33%
Large Surface
33%
Medicine and Dentistry
Innate Immunity
100%
Interleukin-33
100%
Intestine Mucosa
100%
Ulcerative Colitis
75%
Inflammatory Bowel Disease
75%
Prevalence
25%
Pathogen
25%
Serositis
25%
Chronic Disease
25%
Gastrointestinal Tract
25%
Immune System
25%
Etiology
25%
Antigen
25%
Bacterium
25%
Immunology and Microbiology
Innate Immune System
100%
Interleukin-33
100%
Intestine Mucosa
100%
Inflammatory Bowel Disease
75%
Ulcerative Colitis
75%
Prevalence
25%
Infectious Agent
25%
Intestine
25%
Inflammation Response
25%
Antigen
25%
Gastrointestinal Tract
25%
Immune System
25%
Bacterium
25%